Head-to-head dispatch
MEDVidi vs Sprout Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide).
Marked down on: Consult-fee model: medication is not included and its cost is separate
Desk Score
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
$299/mo sema · $349/mo tirz · Verified August 28, 2026
Marked down on: FDA issued Sprout Health Partners LLC dba Sprout Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Sprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 47/100 (C) for MEDVidi. MEDVidi still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
MEDVidi
47/100
C
Sprout Health
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | MEDVidi | Sprout Health |
|---|---|---|
| Semaglutide | Not listed on MEDVidi's site (checked July 16, 2026) | $299/mo |
| Tirzepatide | Not listed on MEDVidi's site (checked July 16, 2026) | $349/mo |
| Coverage | Not listed on MEDVidi's site (checked July 16, 2026) | Not listed on Sprout Health's site (checked August 28, 2026) |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a licensed provider to prescribe brand glp-1 they fill with insurance. | Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding. |
| Desk Score | 47/100C | 86/100B |
The verdict
Desk pick — Sprout HealthSprout Health takes this head-to-head with the higher Desk Score, 86/100 (B) against 47/100 (C) for MEDVidi. MEDVidi still holds its ground where its strengths line up with yours.
Choose MEDVidi if…
People who want a licensed provider to prescribe brand glp-1 they fill with insurance.
Choose Sprout Health if…
Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
$299/mo sema · $349/mo tirz
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: MEDVidi · Sprout Health.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs MEDVidi
- CoreAge Rx vs Sprout Health
- MEDVidi vs Vytora Health
- Sprout Health vs Vytora Health
- MEDVidi vs Pallas Health
- Amazon One Medical vs Sprout Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.